AHR Stock Analysis: Buy, Sell, or Hold?
AHR - American Healthcare REIT, Inc.
$54.31
0.71 (1.32%)
▲
5d:
-4.28%
30d:
-4.03%
90d:
+6.2%
HOLD
LOW Confidence
Analysis Updated: Aug 14, 2026 12:00 AM ET
Earnings: Aug 06, 2026
0d
Get Alerted When AHR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: AHR shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: AHR shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$43.82
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$27.21
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: AHR is currently trading at $54.31, which is considered slightly low relative to its 30-day fair value range of $53.90 to $56.91. The stock's valuation (Forward PE: 60.3) is in line with its historical norms (60.7). Remarkably, the market is currently pricing in an annual earnings decline of 0.2% over the next few years. This pessimistic expectation contrasts with the company's recent 157.5% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, AHR is in a strong uptrend. Immediate support is located at $52.33, while resistance sits at $57.40.
Market Sentiment: AHR scores 66/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $61.53 (+13.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, AHR is in a strong uptrend. Immediate support is located at $52.33, while resistance sits at $57.40.
Market Sentiment: AHR scores 66/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $61.53 (+13.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$53.90 -
$56.91
Company Quality Score
63/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
88.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (66/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($61.53)
- CAUTION: Bottoming setup, but lagging the sector by 11% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$53.90 -
$56.91
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$52.33
Resistance Level
$57.40
Current Trend
Strong Uptrend
Technical data as of
Aug 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
60.34
Wall Street Target
$61.53
(+13.3%)
Revenue Growth (YoY)
24.7%
Earnings Growth (YoY)
157.5%
Profit Margin
4.8%
Valuation Discount vs History
-0.2% cheaper
PE vs Historical
60.3 vs 60.7
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-0.2%
(market-implied from PE analysis)
1-Year Target
$54.20
(0%)
2-Year Target
$54.09
(0%)
3-Year Target
$53.98
(-1%)
3-Yr Target (if PE normalizes)
(PE: 60→61)
$54.30
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 60.3, Growth: 49.9%)
$182.75
(+237%)
Base:
(SPY PE: 20.2, Growth: 49.9%)
$61.26
(+13%)
Bear:
(PE: 17.2, Growth: 49.9%)
$52.07
(-4%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (79x PE), but valuation improves significantly next year (60x PE) as earnings recover.
Trailing PE: 78.82 | Current EPS (TTM): $0.68
Bull Case
$78.04
(+44%)
Analyst growth 32.4%, PE expands to 86.7
Base Case
$70.94
(+31%)
Market implied 32.4%, PE stable at 78.8
Bear Case
$36.45
(-33%)
Severe decline -20.0%, PE contracts to 67.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 60.3 to 60.7
Stabilization Target:
$54.63
(+0.6%)
PE Expansion Potential:
+0.6%
Share & Embed Analysis
Last updated: August 14, 2026 8:54 PM ET
Data refreshes hourly during market hours. Next update: 9:54 PM
Data refreshes hourly during market hours. Next update: 9:54 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AHR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Mark E Foster
SELL
2000 shares
2026-03-25
Top Rated REIT - Healthcare Facilities Stocks
Top-rated stocks in REIT - Healthcare Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VTR
Ventas Inc |
STRONG BUY
20 analysts |
$101 | 64 BUY |
|
WELL
Welltower Inc |
STRONG BUY
20 analysts |
$256 | 64 BUY |
|
DOC
Healthpeak Properties Inc |
STRONG BUY
20 analysts |
$23 | 60 BUY |
|
STRW
Strawberry Fields REIT L… |
STRONG BUY
7 analysts |
$15 | 63 BUY |
|
OHI
Omega Healthcare Investo… |
HOLD
16 analysts |
$52 | 63 BUY |
